Obesity and the risk of new-onset atrial fibrillation.

[1]  P. Sanders,et al.  Electrophysiologic and electroanatomic changes in the human atrium associated with age. , 2004, Journal of the American College of Cardiology.

[2]  Ralph B D'Agostino,et al.  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. , 2004, JAMA.

[3]  B. Gersh,et al.  The Natural History of Lone Atrial Flutter , 2004, Annals of Internal Medicine.

[4]  B. Gersh,et al.  Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation , 2003, Circulation.

[5]  Douglas W Mahoney,et al.  Left atrial volume as an index of left atrial size: a population-based study. , 2003, Journal of the American College of Cardiology.

[6]  A. Mokdad,et al.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.

[7]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[8]  F. Leonetti,et al.  Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. , 2002, Obesity research.

[9]  M. Allessie,et al.  Electrical, contractile and structural remodeling during atrial fibrillation. , 2002, Cardiovascular research.

[10]  Ana Ruigómez,et al.  Incidence of chronic atrial fibrillation in general practice and its treatment pattern. , 2002, Journal of clinical epidemiology.

[11]  Richard B. Devereux,et al.  Correlates of Left Atrial Size in Hypertensive Patients With Left Ventricular Hypertrophy: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study , 2002, Hypertension.

[12]  L. Wilhelmsen,et al.  Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors , 2001, Journal of internal medicine.

[13]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[14]  Arya M. Sharma,et al.  The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension , 2001, Journal of Molecular Medicine.

[15]  L. Orci,et al.  Lipotoxic heart disease in obese rats: implications for human obesity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Pelat,et al.  Impaired atrial M(2)-cholinoceptor function in obesity-related hypertension. , 1999, Hypertension.

[17]  H. Naito,et al.  Obesity is associated with increased myocardial oxidative stress , 1999, International Journal of Obesity.

[18]  G A Colditz,et al.  Abdominal adiposity and coronary heart disease in women. , 1998, JAMA.

[19]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[20]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary , 1998 .

[21]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. , 1998, WMJ : official publication of the State Medical Society of Wisconsin.

[22]  D Spiegelman,et al.  Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. , 1995, American journal of epidemiology.

[23]  D. Levy,et al.  Influence of blood pressure on left atrial size. The Framingham Heart Study. , 1995, Hypertension.

[24]  F A Mathewson,et al.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.

[25]  D. Levy,et al.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.

[26]  S. Vaziri,et al.  Echocardiographic Predictors of Nonrheumatic Atrial Fibrillation: The Framingham Heart Study , 1994, Circulation.

[27]  D. Levy,et al.  The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. , 1991, JAMA.

[28]  S. Meterissian,et al.  Assessment of cardiac function in patients who were morbidly obese. , 1990, Surgery.

[29]  W. Kannel,et al.  Considerations in the Use of Echocardiography in Epidemiology The Framingham Study , 1987, Hypertension.

[30]  F. Dunn,et al.  Borderline Hypertension and Obesity: Two Prehypertensive States with Elevated Cardiac Output , 1982, Circulation.

[31]  W. Kannel,et al.  An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.

[32]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[33]  T. Cottle.  The Life Study , 1973 .

[34]  W. Kannel,et al.  Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. , 1969, Annals of internal medicine.

[35]  T. Dawber,et al.  Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.

[36]  D.,et al.  Regression Models and Life-Tables , 2022 .